Biotechnology & Drugs News


Gentherm Partners With ThermoAnalytics To Improve Thermal Comfort Predictions

Merck To Present Data From Three Cohorts Of Phase 1b/2 KEYNOTE-365 Study

West Pharma Q4 Reported EPS $0.69; Adj EPS $0.73

Novartis Receives FDA Approval For Egaten For Treatment Of Fascioliasis

Johnson & Johnson: Ethicon Enters Definitive Agreement To Acquire Auris Health

Teva Q4 Non-GAAP EPS $0.53, GAAP Loss Per Share $2.85

Clinigen Group Signs Agreement With Novartis To Acquire US Rights To Proleukin